4 results on '"U. Mause"'
Number of results to display per page
Search Results
2. Effect of anticonvulsive treatment on neuropsychological performance in children with BECTS
- Author
-
Moritz Tacke, Lucia Gerstl, Florian Heinen, Isabel Heukaeufer, Michaela Bonfert, Thomas Bast, Sonia Cornell, Bernd Axel Neubauer, Ingo Borggraefe, F.A.M. Baumeister, M. Baethmann, B. Schreiber-Gollwitzer, K. Bentele, C. Blank, J. Held, H.M. Blank, K. Liebrich, H. Bode, J. Braun, F. Bosch, R. Wagner, U. Brandl, K. Wetzel, K. Brockmann, C. Schlockwerder, P. Dahlem, I. Baudler, J.P. Ernst, H. Mayer, E. Feldmann, A. Pattber-Wolff, A. Fiedler, S. Sonnleitner, M. Gerigk, S. Heß, T. Feiereis, C. Hikel, H.G. Hoffmann, A. Rickeshenrich, M. Kieslich, R. Dewitz, M. Baz Bartels, J. Klepper, S. Kleuker, G. Kluger, A. Kirsch, H. Koch, U. Meerpohl, W. Koch, R. Korinthenberg, B. Stehle-Renner, I. Krois, A. Wegener, H. Kühne, C. Weiß, G. Kurlemann, U. Elkemann, M. Mandl, A. Friedl, U. Mause, M. Müller, P. Navratil, U. Iken, J. Opp, J. Walter, J. Penzien, V. Prietsch, B. Siegrist, A. Quattländer, D. Rating, G. Reuner, U. Schara, M.G. Shamdeen, H. Struchholz, A. Sprinz, H. Wendker-Magrabi, U. Stephani, H. Muhle, G. Carlsson, H.M. Straßburg, H. Ottensmeier, B. Töpke, K. Tatsek, R. Trollmann, E. Poida-Herzing, E. Tuschen-Hofstätter, M. Menschig, S. Waltz, A. Pickartz, G. Weber, T. Gehnen, F.U. Wien, J. Antemann, M. Wolff, E. Serra, T. Polster, H. Freitag, Ö Sönmez, K. Rheinhardt, M. Traus, A. Schröder, S. Hoovey, C. Navratil, and Schara, Ulrike (Beitragende*r)
- Subjects
Male ,Levetiracetam ,Medizin ,Thiazines ,Child Behavior ,Neuropsychological Tests ,Verbal learning ,03 medical and health sciences ,Executive Function ,0302 clinical medicine ,Cognition ,Double-Blind Method ,Memory ,030225 pediatrics ,medicine ,Humans ,Cognitive skill ,Effects of sleep deprivation on cognitive performance ,Neuropsychological assessment ,Child ,Language ,Intelligence Tests ,medicine.diagnostic_test ,Kaufman Assessment Battery for Children ,Neuropsychology ,General Medicine ,Epilepsy, Rolandic ,Piracetam ,Space Perception ,Pediatrics, Perinatology and Child Health ,Mental Recall ,Anticonvulsants ,Female ,Neurology (clinical) ,Verbal memory ,Psychology ,030217 neurology & neurosurgery ,Psychomotor Performance ,Clinical psychology - Abstract
Introduction Benign epilepsy with centrotemporal spikes (BECTS) is a common epilepsy syndrome in childhood. Besides the occurrence of seizures, mild cognitive impairments and behavioral problems affecting language skills, spatial perception, memory, executive function, and academic achievement might be present. There is no international consensus about the decision whether or not to treat affected children. The influence of treatment on cognitive functions is debated. Methods Patients diagnosed with BECTS were assessed in short term auditory memory, long-term verbal memory, intelligence and behavior using the “number recall” test from the Kaufman assessment battery for children, the “verbal learning memory test”, the “culture free intelligence test” and the “child behavior checklist” prior to a randomized controlled antiepileptic therapy and after a treatment period of 6 months with either sulthiame or levetiracetam. Results 43 of 44 randomized patients were analyzed. One patient had to be excluded due to protocol violation. Patients who completed the study showed a non-significant improvement in parent-reported behavioral problems under therapy. Cognitive skills were not affected. Conclusion The present data suggest that antiepileptic drug treatment of children with BECTS with either sulthiame or levetiracetam does not affect cognitive performance. Behavior improved in a subset of patients though not reaching statistical significance.
- Published
- 2016
3. Effects of Levetiracetam and Sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial.
- Author
-
Tacke M, Borggraefe I, Gerstl L, Heinen F, Vill K, Bonfert M, Bast T, Neubauer BA, Baumeister F, Baethmann M, Bentele K, Blank C, Blank HM, Bode H, Bosch F, Brandl U, Brockmann K, Dahlem P, Ernst JP, Feldmann E, Fiedler A, Gerigk M, Heß S, Hikel C, Hoffmann HG, Kieslich M, Klepper J, Kluger G, Koch H, Koch W, Korinthenberg R, Krois I, Kühne H, Kurlemann G, Mandl M, Mause U, Navratil P, Opp J, Penzien J, Prietsch V, Quattländer A, Rating D, Schara U, Shamdeen MG, Sprinz A, Wendker-Magrabi H, Stephani U, Muhle H, Straßburg HM, Töpke B, Trollmann R, Tuschen-Hofstätter E, Waltz S, Weber G, Wien FU, Wolff M, Polster T, Freitag H, Sönmez Ö, Reinhardt K, Traus M, and Hoovey Z
- Subjects
- Child, Double-Blind Method, Electroencephalography, Female, Germany, Humans, Levetiracetam, Male, Piracetam therapeutic use, Retrospective Studies, Statistics, Nonparametric, Treatment Outcome, Anticonvulsants therapeutic use, Brain Waves drug effects, Epilepsy, Rolandic drug therapy, Piracetam analogs & derivatives, Thiazines therapeutic use
- Abstract
Purpose: BECTS (benign childhood epilepsy with centrotemporal spikes) is associated with characteristic EEG findings. This study examines the influence of anti-convulsive treatment on the EEG., Methods: In a randomized controlled trial including 43 children with BECTS, EEGs were performed prior to treatment with either Sulthiame or Levetiracetam as well as three times under treatment. Using the spike-wave-index, the degree of EEG pathology was quantified. The EEG before and after initiation of treatment was analyzed. Both treatment arms were compared and the EEG of the children that were to develop recurrent seizures was compared with those that were successfully treated., Results: Regardless of the treatment agent, the spike-wave-index was reduced significantly under treatment. There were no differences between the two treatment groups. In an additional analysis, the EEG characteristics of the children with recurrent seizures differed statistically significant from those that did not have any further seizures., Conclusion: Both Sulthiame and Levetiracetam influence the EEG of children with BECTS. Persistent EEG pathologies are associated with treatment failures., (Copyright © 2018 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
4. PRRT2 mutations are the major cause of benign familial infantile seizures.
- Author
-
Schubert J, Paravidino R, Becker F, Berger A, Bebek N, Bianchi A, Brockmann K, Capovilla G, Dalla Bernardina B, Fukuyama Y, Hoffmann GF, Jurkat-Rott K, Anttonen AK, Kurlemann G, Lehesjoki AE, Lehmann-Horn F, Mastrangelo M, Mause U, Müller S, Neubauer B, Püst B, Rating D, Robbiano A, Ruf S, Schroeder C, Seidel A, Specchio N, Stephani U, Striano P, Teichler J, Turkdogan D, Vigevano F, Viri M, Bauer P, Zara F, Lerche H, and Weber YG
- Subjects
- Adolescent, Adult, Aged, Child, Child, Preschool, Humans, Infant, Male, Middle Aged, Mutation, Pedigree, Seizures, Febrile genetics, Membrane Proteins genetics, Nerve Tissue Proteins genetics, Spasms, Infantile genetics
- Abstract
Mutations in PRRT2 have been described in paroxysmal kinesigenic dyskinesia (PKD) and infantile convulsions with choreoathetosis (PKD with infantile seizures), and recently also in some families with benign familial infantile seizures (BFIS) alone. We analyzed PRRT2 in 49 families and three sporadic cases with BFIS only of Italian, German, Turkish, and Japanese origin and identified the previously described mutation c.649dupC in an unstable series of nine cytosines to occur in 39 of our families and one sporadic case (77% of index cases). Furthermore, three novel mutations were found in three other families, whereas 17% of our index cases did not show PRRT2 mutations, including a large family with late-onset BFIS and febrile seizures. Our study further establishes PRRT2 as the major gene for BFIS alone., (© 2012 Wiley Periodicals, Inc.)
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.